500 related articles for article (PubMed ID: 26414169)
1. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutiérrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
Medicine (Baltimore); 2015 May; 94(17):e781. PubMed ID: 25929922
[TBL] [Abstract][Full Text] [Related]
3. Immune activation throughout a boosted darunavir monotherapy simplification strategy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutiérrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
Clin Microbiol Infect; 2014 Dec; 20(12):1297-303. PubMed ID: 24372830
[TBL] [Abstract][Full Text] [Related]
4. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
5. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.
Feuth T; Arends JE; Fransen JH; Nanlohy NM; van Erpecum KJ; Siersema PD; Hoepelman AI; van Baarle D
PLoS One; 2013; 8(3):e59302. PubMed ID: 23555014
[TBL] [Abstract][Full Text] [Related]
6. Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
Majekodunmi AO; Thorne C; Malyuta R; Volokha A; Callard RE; Klein NJ; Lewis J;
Pediatr Infect Dis J; 2017 May; 36(5):e123-e129. PubMed ID: 28403051
[TBL] [Abstract][Full Text] [Related]
7. Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.
Massanella M; Tural C; Papagno L; Garcia E; Jou A; Bofill M; Autran B; Clotet B; Blanco J
Antivir Ther; 2010; 15(3):333-42. PubMed ID: 20516553
[TBL] [Abstract][Full Text] [Related]
8. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
[TBL] [Abstract][Full Text] [Related]
10. Impact of T cell activation, HIV replication and hepatitis C virus infection on neutrophil CD64 expression.
Morquin D; Tuaillon E; Makinson A; Bendriss S; Le Moing V; Reynes J
Cytometry B Clin Cytom; 2017 Nov; 92(6):492-497. PubMed ID: 27221825
[TBL] [Abstract][Full Text] [Related]
11. [Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus].
Shmagel KV; Shmagel NG; Korolevskaya LB; Saydakova EV; Chereshnev VA
Ter Arkh; 2016; 88(11):22-28. PubMed ID: 28005028
[TBL] [Abstract][Full Text] [Related]
12. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis.
Girón-Ortega JA; Márquez-Coello M; Gutiérrez-Saborido D; Arizcorreta A; Cuesta-Sancho S; Girón-González JA
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1863-1871. PubMed ID: 33822285
[TBL] [Abstract][Full Text] [Related]
13. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
[TBL] [Abstract][Full Text] [Related]
15. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.
Kovacs A; Karim R; Mack WJ; Xu J; Chen Z; Operskalski E; Frederick T; Landay A; Voris J; Spencer LS; Young MA; Tien PC; Augenbraun M; Strickler HD; Al-Harthi L
J Infect Dis; 2010 Mar; 201(6):823-34. PubMed ID: 20151840
[TBL] [Abstract][Full Text] [Related]
16. Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.
Williams SK; Donaldson E; Van der Kleij T; Dixon L; Fisher M; Tibble J; Gilleece Y; Klenerman P; Banham AH; Howard M; Webster DP
J Viral Hepat; 2014 Apr; 21(4):251-9. PubMed ID: 24597693
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Myeloid-Derived Suppressor Cells in Human Immunodeficiency Virus-1/ Hepatitis C Virus-coinfected Patients.
Lei AH; Yang Q; Cai WP; Liu YF; Lan Y; Qin AP; Hu FY; Zhou J
Scand J Immunol; 2016 Jun; 83(6):438-44. PubMed ID: 26972443
[TBL] [Abstract][Full Text] [Related]
18. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
[TBL] [Abstract][Full Text] [Related]
19. Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort.
Di Biagio A; Nicolini LA; Lorenzini P; Puoti M; Antinori A; Cozzi-Lepri A; Gori A; Vecchiet J; Mussini C; Andreoni M; Viscoli C; d'Arminio Monforte A; For The Icona Foundation Study Group
HIV Clin Trials; 2014; 15(4):151-60. PubMed ID: 25143024
[TBL] [Abstract][Full Text] [Related]
20. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
